NB

Neil Butt

Chief Executive Officer

Orbit Discovery

Oxford, England


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Orbit Discovery
Industry
research
Employees
31.0
Seniority
C suite
Annual Revenue
3500000.0
Total Funding
17023387.0
Latest Funding
Venture (Round not Specified)

Technologies

Outlook Amazon AWS Flywheel Leadfeeder Salesforce reCAPTCHA Google Font API Google Tag Manager YouTube Bootstrap Framework WordPress.org Mobile Friendly Python

Keywords

peptide display nonnatural amino acids cellsurface targets transcription translation translation on bead drug discovery constrained peptides peptide drugs biotechnology research peptide discovery therapeutic applications radionuclide targeting nucleic acid targeting targeted protein degradation soluble protein targeting high-throughput screening facs technology microfluidics affinity screening functional screening gpcr agonism gpcr antagonism customizable services bead-based display system chemical diversity linear peptides macrocyclic peptides reporter cell lines peptide libraries binding peptide identification bioinformatics internalization assays massive chemical libraries soluble targets molecular glues targeted therapies precision medicine tissue-specific delivery aggressive binding optimization screening platforms targeting ligands biotechnology innovation therapeutic candidates high-affinity binders cellular functional screening peptide conjugates screening methodologies peptide design drug development protein-protein interactions disease-specific targets validation methods therapeutic hits identification pharmaceutical collaborations biopharmaceutical development advanced screening techniques peptide microarrays information technology & services biotechnology

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans